Advertisement
Research Article| Volume 125, ISSUE 5, P720-726, March 01, 2020

Download started.

Ok

Incidence and In-Hospital Outcomes of Patients Presenting With Stent Thrombosis (from the Japanese Nationwide Percutaneous Coronary Intervention Registry)

Published:December 09, 2019DOI:https://doi.org/10.1016/j.amjcard.2019.12.005
      Clinical presentation of stent thrombosis (ST) and its sequela under contemporary practice have not been fully elucidated largely due to rare incidence of ST. We sought to assess the characteristics in patients with clinical presentation of ST and their in-hospital outcomes, utilizing nationwide registration system for percutaneous coronary interventions (J-PCI). The present study included acute coronary syndrome (ACS) patients undergoing PCI with clinical findings of definite ST from January 2014 to December 2016. Patients’ characteristics, in-hospital mortality and its composite with periprocedural complications were evaluated. Full match comparison was performed. During the study period, 256,610 ACS patients (37.9% of total PCI cases) underwent PCI and 1,367 ST patients (1.9%) were identified from 73,241 ACS patients’ records who had a history of previous PCI. Overall, patients with ST were younger but had higher incidence of previous myocardial infarction, compared with those without. In addition, ST patients had increased rate of crude in-hospital death (4.8% vs 1.1%, p <0.001). After full match comparison, the incidence of recurrent ST (post-PCI) was significantly higher in ST patients when compared with ACS patients presenting without ST (4.3% vs 0.9%, p <0.001). Despite younger age, patients with ST had significantly higher incidence of in-hospital mortality and cardiovascular complications, including recurrent ST, compared with those without.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Serruys PW
        • Farooq V
        • Kalesan B
        • de Vries T
        • Buszman P
        • Linke A
        • Ischinger T
        • Klauss V
        • Eberli F
        • Wijns W
        • Morice MC
        • Di Mario C
        • Corti R
        • Antoni D
        • Sohn HY
        • Eerdmans P
        • Rademaker-Havinga T
        • van Es GA
        • Meier B
        • Juni P
        • Windecker S
        Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
        JACC Cardiovasc Interv. 2013; 6: 777-789
        • Smits PC
        • Vlachojannis GJ
        • McFadden EP
        • Royaards KJ
        • Wassing J
        • Joesoef KS
        • van Mieghem C
        • van de Ent M
        Final 5-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice: the COMPARE trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
        JACC Cardiovasc Interv. 2015; 8: 1157-1165
        • Palmerini T
        • Biondi-Zoccai G
        • Della Riva D
        • Stettler C
        • Sangiorgi D
        • D'Ascenzo F
        • Kimura T
        • Briguori C
        • Sabate M
        • Kim HS
        • De Waha A
        • Kedhi E
        • Smits PC
        • Kaiser C
        • Sardella G
        • Marullo A
        • Kirtane AJ
        • Leon MB
        • Stone GW
        Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
        Lancet. 2012; 379: 1393-1402
        • Palmerini T
        • Benedetto U
        • Biondi-Zoccai G
        • Della Riva D
        • Bacchi-Reggiani L
        • Smits PC
        • Vlachojannis GJ
        • Jensen LO
        • Christiansen EH
        • Berencsi K
        • Valgimigli M
        • Orlandi C
        • Petrou M
        • Rapezzi C
        • Stone GW
        Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
        J Am Coll Cardiol. 2015; 65: 2496-2507
        • Wiviott SD
        • Braunwald E
        • McCabe CH
        • Montalescot G
        • Ruzyllo W
        • Gottlieb S
        • Neumann FJ
        • Ardissino D
        • De Servi S
        • Murphy SA
        • Riesmeyer J
        • Weerakkody G
        • Gibson CM
        • Antman EM
        • Investigators T-T
        Prasugrel versus clopidogrel in patients with acute coronary syndromes.
        N Engl J Med. 2007; 357: 2001-2015
        • Cannon CP
        • Harrington RA
        • James S
        • Ardissino D
        • Becker RC
        • Emanuelsson H
        • Husted S
        • Katus H
        • Keltai M
        • Khurmi NS
        • Kontny F
        • Lewis BS
        • Steg PG
        • Storey RF
        • Wojdyla D
        • Wallentin L
        • inhibition PL and patient Outcomes I
        Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.
        Lancet. 2010; 375: 283-293
        • Vlachojannis GJ
        • Smits PC
        • Hofma SH
        • Togni M
        • Vazquez N
        • Valdes M
        • Voudris V
        • Slagboom T
        • Goy JJ
        • den Heijer P
        • van der Ent M
        Biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: final 5-year report from the COMPARE II trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
        JACC Cardiovasc Interv. 2017; 10: 1215-1221
        • Galloe AM
        • Kelbaek H
        • Thuesen L
        • Hansen HS
        • Ravkilde J
        • Hansen PR
        • Christiansen EH
        • Abildgaard U
        • Stephansen G
        • Lassen JF
        • Engstrom T
        • Jensen JS
        • Jeppesen JL
        • Bligaard N
        • Investigators SOI
        10-year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents.
        J Am Coll Cardiol. 2017; 69: 616-624
        • de la Torre-Hernandez JM
        • Alfonso F
        • Hernandez F
        • Elizaga J
        • Sanmartin M
        • Pinar E
        • Lozano I
        • Vazquez JM
        • Botas J
        • Perez de Prado A
        • Hernandez JM
        • Sanchis J
        • Nodar JM
        • Gomez-Jaume A
        • Larman M
        • Diarte JA
        • Rodriguez-Collado J
        • Rumoroso JR
        • Lopez-Minguez JR
        • Mauri J
        • Group ES
        Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos).
        J Am Coll Cardiol. 2008; 51: 986-990
        • Kimura T
        • Morimoto T
        • Kozuma K
        • Honda Y
        • Kume T
        • Aizawa T
        • Mitsudo K
        • Miyazaki S
        • Yamaguchi T
        • Hiyoshi E
        • Nishimura E
        • Isshiki T
        • Investigators R
        Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).
        Circulation. 2010; 122: 52-61
        • Sarno G
        • Lagerqvist B
        • Frobert O
        • Nilsson J
        • Olivecrona G
        • Omerovic E
        • Saleh N
        • Venetzanos D
        • James S
        Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
        Eur Heart J. 2012; 33: 606-613
        • Sakakura K
        • Inohara T
        • Kohsaka S
        • Amano T
        • Uemura S
        • Ishii H
        • Kadota K
        • Nakamura M
        • Funayama H
        • Fujita H
        • Momomura SI
        Incidence and determinants of complications in rotational atherectomy: insights from the national clinical data (J-PCI Registry).
        Circ Cardiovasc Interv. 2016; : 9
        • Numasawa Y
        • Inohara T
        • Ishii H
        • Kuno T
        • Kodaira M
        • Kohsaka S
        • Fujii K
        • Uemura S
        • Amano T
        • Kadota K
        • Nakamura M
        Comparison of outcomes of women versus men with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the Japanese Nationwide Registry).
        Am J Cardiol. 2017; 119: 826-831
        • Yamaji K
        • Kohsaka S
        • Morimoto T
        • Fujii K
        • Amano T
        • Uemura S
        • Akasaka T
        • Kadota K
        • Nakamura M
        • Kimura T
        • Investigators JPR
        Relation of ST-segment elevation myocardial infarction to daily ambient temperature and air pollutant levels in a Japanese Nationwide Percutaneous Coronary Intervention Registry.
        Am J Cardiol. 2017; 119: 872-880
        • Inohara T
        • Kohsaka S
        • Yamaji K
        • Amano T
        • Fujii K
        • Oda H
        • Uemura S
        • Kadota K
        • Miyata H
        • Nakamura M
        • Investigators JPR
        Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: a report from the Japanese Nationwide Registry.
        JACC Cardiovasc Interv. 2017; 10: 918-927
        • Cutlip DE
        • Windecker S
        • Mehran R
        • Boam A
        • Cohen DJ
        • van Es GA
        • Steg PG
        • Morel MA
        • Mauri L
        • Vranckx P
        • McFadden E
        • Lansky A
        • Hamon M
        • Krucoff MW
        • Serruys PW
        • Academic Research C
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Mauri L
        • Hsieh WH
        • Massaro JM
        • Ho KK
        • D'Agostino R
        • Cutlip DE
        Stent thrombosis in randomized clinical trials of drug-eluting stents.
        N Engl J Med. 2007; 356: 1020-1029
        • Armstrong EJ
        • Feldman DN
        • Wang TY
        • Kaltenbach LA
        • Yeo KK
        • Wong SC
        • Spertus J
        • Shaw RE
        • Minutello RM
        • Moussa I
        • Ho KK
        • Rogers JH
        • Shunk KA
        Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis.
        JACC Cardiovasc Interv. 2012; 5: 131-140
        • Kerkmeijer LS
        • Claessen BE
        • Baber U
        • Sartori S
        • Chandrasekhar J
        • Stefanini GG
        • Stone GW
        • Steg PG
        • Chieffo A
        • Weisz G
        • Windecker S
        • Mikhail GW
        • Kastrati A
        • Morice MC
        • Dangas GD
        • de Winter RJ
        • Mehran R
        Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis.
        Int J Cardiol. 2018; 263: 24-28
        • Kimura T
        • Morimoto T
        • Nakagawa Y
        • Tamura T
        • Kadota K
        • Yasumoto H
        • Nishikawa H
        • Hiasa Y
        • Muramatsu T
        • Meguro T
        • Inoue N
        • Honda H
        • Hayashi Y
        • Miyazaki S
        • Oshima S
        • Honda T
        • Shiode N
        • Namura M
        • Sone T
        • Nobuyoshi M
        • Kita T
        • Mitsudo K
        • j-Cypher Registry I
        Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
        Circulation. 2009; 119: 987-995
        • Chechi T
        • Vecchio S
        • Vittori G
        • Giuliani G
        • Lilli A
        • Spaziani G
        • Consoli L
        • Baldereschi G
        • Biondi-Zoccai GG
        • Sheiban I
        • Margheri M
        ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients.
        J Am Coll Cardiol. 2008; 51: 2396-2402
        • Wenaweser P
        • Rey C
        • Eberli FR
        • Togni M
        • Tuller D
        • Locher S
        • Remondino A
        • Seiler C
        • Hess OM
        • Meier B
        • Windecker S
        Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
        Eur Heart J. 2005; 26: 1180-1187
        • Alfonso F
        • Suarez A
        • Perez-Vizcayno MJ
        • Moreno R
        • Escaned J
        • Banuelos C
        • Jimenez P
        • Bernardo E
        • Angiolillo DJ
        • Hernandez R
        • Macaya C
        Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis.
        J Am Coll Cardiol. 2007; 50: 2095-2097
        • Cook S
        • Wenaweser P
        • Togni M
        • Billinger M
        • Morger C
        • Seiler C
        • Vogel R
        • Hess O
        • Meier B
        • Windecker S
        Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
        Circulation. 2007; 115: 2426-2434